<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers — Live Feed</title><link>https://www.live-feeds.com/feed/trump-reportedly-plans-to-announce-new-drug-pricing-deals-with-nearly-a-dozen-drugmakers</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/trump-reportedly-plans-to-announce-new-drug-pricing-deals-with-nearly-a-dozen-drugmakers/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Trump Announces Medicaid Drug Pricing Deals With Nine Pharma Companies</title><link>https://www.live-feeds.com/feed/trump-reportedly-plans-to-announce-new-drug-pricing-deals-with-nearly-a-dozen-drugmakers</link><guid isPermaLink="false">https://www.live-feeds.com/feed/trump-reportedly-plans-to-announce-new-drug-pricing-deals-with-nearly-a-dozen-drugmakers#u53904</guid><pubDate>Tue, 01 Sep 2026 11:36:43 +0000</pubDate><description>The Trump administration has established new Medicaid drug pricing agreements with nine midsize pharmaceutical and biotechnology firms. These deals ensure that every included drug is provided at the lowest available prices. Participating companies include Sun Pharmaceutical Industries Ltd, Bridgebio Pharma Inc, and UCB SA. This latest set of agreements expands on a previous initiative started last year that secured pricing deals with 17 of the world&amp;#039;s largest drugmakers, such as Amgen, Eli Lilly, and Pfizer.Why it mattersThese agreements target the cost of prescription medications within </description></item>
</channel></rss>